Focused ultrasound with chemotherapy shows survival benefit for brain cancer patients, clinical trial finds

Patients with the deadliest form of brain cancer, glioblastoma, who received MRI-guided focused ultrasound with standard-of-care chemotherapy had a nearly 40% increase in overall survival in a landmark trial of 34 patients led by University of…

Continue Reading

News Source: medicalxpress.com